Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00293293 · ClinicalTrials.gov registry record · NA
Outcomes in Ovarian Cancer and Fallopian Tube Cancer Patients Using Complementary Alternative Medicine
A NA study, sponsored by Masonic Cancer Center, University of Minnesota.
- Completed
- Registry status
- NA
- Development phase
- 43
- Enrollment target
NCT00293293 is a NA study that has completed, run by Masonic Cancer Center, University of Minnesota. The registered enrollment target is 43 participants.
The verdict
NCT00293293, a NA study, has completed, sponsored by Masonic Cancer Center, University of Minnesota.
- COMPLETED
- Registry status
- NA
- Development phase
- 43 participants
- Enrollment target
Study Summary
RATIONALE: Chemotherapy, such as paclitaxel and carboplatin, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Hypnosis, massage therapy, and healing touch may improve the quality of life of patients who are undergoing chemotherapy. PURPOSE: This randomized clinical trial is studying how well giving hypnosis, massage therapy and healing touch changes outcomes in women receiving chemotherapy for newly diagnosed epithelial ovarian, fallopian tube or peritoneal cavity cancer.
Interventions
- OTHER massage therapy
- OTHER healing touch
- OTHER hypnosis
- DRUG Standard chemotherapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2005-05 |
| Est. Completion | 2010-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00293293
The ClinicalTrials.gov registry entry for NCT00293293 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 43 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Masonic Cancer Center, University of Minnesota, which has 249 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which massage therapy is the first listed.
NCT00293293 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00293293 about?
NCT00293293 is a clinical study titled "Outcomes in Ovarian Cancer and Fallopian Tube Cancer Patients Using Complementary Alternative Medicine". RATIONALE: Chemotherapy, such as paclitaxel and carboplatin, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Hypnosis, massage therapy, and healing touch may improve the quality of life of patients who are undergoing chemothera...
What is the current status of trial NCT00293293?
This trial is currently completed. It is a NA study. The enrollment target is 43 participants. The study started on 2005-05. Estimated completion is 2010-01.
What interventions are being tested in trial NCT00293293?
The interventions under investigation include: massage therapy (OTHER), healing touch (OTHER), hypnosis (OTHER), Standard chemotherapy (DRUG).
Who is sponsoring clinical trial NCT00293293?
This trial is sponsored by Masonic Cancer Center, University of Minnesota, which has 249 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.